Cargando…

Vitamin D inhibits pro-inflammatory cytokines in the airways of cystic fibrosis patients infected by Pseudomonas aeruginosa- pilot study

BACKGROUND: Vitamin D plays an important role in inflammatory responses after antigen exposure. Interleukin-23 (Il-23) promotes Il-17-dependent inflammation during Pseudomonas aeruginosa (P. aeruginosa) pulmonary infection. We aimed to compare the ability of calcitriol and cholecalciferol to modulat...

Descripción completa

Detalles Bibliográficos
Autores principales: Olszowiec-Chlebna, M., Koniarek-Maniecka, A., Brzozowska, A., Błauż, A., Rychlik, B., Stelmach, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440129/
https://www.ncbi.nlm.nih.gov/pubmed/30922377
http://dx.doi.org/10.1186/s13052-019-0634-x
_version_ 1783407338780098560
author Olszowiec-Chlebna, M.
Koniarek-Maniecka, A.
Brzozowska, A.
Błauż, A.
Rychlik, B.
Stelmach, I.
author_facet Olszowiec-Chlebna, M.
Koniarek-Maniecka, A.
Brzozowska, A.
Błauż, A.
Rychlik, B.
Stelmach, I.
author_sort Olszowiec-Chlebna, M.
collection PubMed
description BACKGROUND: Vitamin D plays an important role in inflammatory responses after antigen exposure. Interleukin-23 (Il-23) promotes Il-17-dependent inflammation during Pseudomonas aeruginosa (P. aeruginosa) pulmonary infection. We aimed to compare the ability of calcitriol and cholecalciferol to modulate the inflammatory response of the CF airways infected with P. aeruginosa. METHODS: This was a randomized, placebo-controlled, double-blind, cross-over trial. Twenty-three patients with CF (aged 6–19), chronically infected by P. aeruginosa were randomly assigned to: calcitriol group receiving 1,25(OH)(2)D 0,5 mcg daily or cholecalciferol group receiving cholecalciferol 1000 IU daily for three months. The levels of Il-23 and Il-17A in the exhaled breath concentrate (EBC) were measured. Calcium-phosphorus balance was also evaluated (serum concentration of calcium, phosphorus, 25OHD, parathormone (PTH) and calcium/creatinine ratio in urine). Data were analyzed using means of Stata/Special Edition, release 14.2. A level of P < 0.05 was considered statistically significant. RESULTS: The level of Il-17A in EBC significantly decreased in calcitriol group from 0,475 pg/mL (± SD 0,515 pg/mL) to 0,384 pg/mL (± SD 0,429 pg/mL) (p = 0,008); there was no change in cholecalciferol group (p = 0,074). The level of Il-23 in EBC did not significantly change in calcitriol group (p = 0,086); there was significant decrease in cholecalciferol group from 8,90 pg/mL (± SD 4,07 pg/mL) to 7,33 pg/mL (± SD 3,88 pg/mL) (p = 0,001). In calcitriol group serum phosphorus and PTH significantly decreased (p = 0,021 and p = 0,019 respectively), the concentration of calcium significantly increased (p = 0,001); there were no changes in cholecalciferol group. CONCLUSIONS: Both analogs of vitamin D revealed their anti-inflammatory effect and reduced the level of Il-17A and Il-23 in the airway of CF patients with chronic P. aeruginosa infection. We observed improvement in calcium-phosphorus metabolism after supplementation with calcitriol, without adverse effects. It is recommended to use vitamin D in CF patients.
format Online
Article
Text
id pubmed-6440129
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64401292019-04-11 Vitamin D inhibits pro-inflammatory cytokines in the airways of cystic fibrosis patients infected by Pseudomonas aeruginosa- pilot study Olszowiec-Chlebna, M. Koniarek-Maniecka, A. Brzozowska, A. Błauż, A. Rychlik, B. Stelmach, I. Ital J Pediatr Research BACKGROUND: Vitamin D plays an important role in inflammatory responses after antigen exposure. Interleukin-23 (Il-23) promotes Il-17-dependent inflammation during Pseudomonas aeruginosa (P. aeruginosa) pulmonary infection. We aimed to compare the ability of calcitriol and cholecalciferol to modulate the inflammatory response of the CF airways infected with P. aeruginosa. METHODS: This was a randomized, placebo-controlled, double-blind, cross-over trial. Twenty-three patients with CF (aged 6–19), chronically infected by P. aeruginosa were randomly assigned to: calcitriol group receiving 1,25(OH)(2)D 0,5 mcg daily or cholecalciferol group receiving cholecalciferol 1000 IU daily for three months. The levels of Il-23 and Il-17A in the exhaled breath concentrate (EBC) were measured. Calcium-phosphorus balance was also evaluated (serum concentration of calcium, phosphorus, 25OHD, parathormone (PTH) and calcium/creatinine ratio in urine). Data were analyzed using means of Stata/Special Edition, release 14.2. A level of P < 0.05 was considered statistically significant. RESULTS: The level of Il-17A in EBC significantly decreased in calcitriol group from 0,475 pg/mL (± SD 0,515 pg/mL) to 0,384 pg/mL (± SD 0,429 pg/mL) (p = 0,008); there was no change in cholecalciferol group (p = 0,074). The level of Il-23 in EBC did not significantly change in calcitriol group (p = 0,086); there was significant decrease in cholecalciferol group from 8,90 pg/mL (± SD 4,07 pg/mL) to 7,33 pg/mL (± SD 3,88 pg/mL) (p = 0,001). In calcitriol group serum phosphorus and PTH significantly decreased (p = 0,021 and p = 0,019 respectively), the concentration of calcium significantly increased (p = 0,001); there were no changes in cholecalciferol group. CONCLUSIONS: Both analogs of vitamin D revealed their anti-inflammatory effect and reduced the level of Il-17A and Il-23 in the airway of CF patients with chronic P. aeruginosa infection. We observed improvement in calcium-phosphorus metabolism after supplementation with calcitriol, without adverse effects. It is recommended to use vitamin D in CF patients. BioMed Central 2019-03-29 /pmc/articles/PMC6440129/ /pubmed/30922377 http://dx.doi.org/10.1186/s13052-019-0634-x Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Olszowiec-Chlebna, M.
Koniarek-Maniecka, A.
Brzozowska, A.
Błauż, A.
Rychlik, B.
Stelmach, I.
Vitamin D inhibits pro-inflammatory cytokines in the airways of cystic fibrosis patients infected by Pseudomonas aeruginosa- pilot study
title Vitamin D inhibits pro-inflammatory cytokines in the airways of cystic fibrosis patients infected by Pseudomonas aeruginosa- pilot study
title_full Vitamin D inhibits pro-inflammatory cytokines in the airways of cystic fibrosis patients infected by Pseudomonas aeruginosa- pilot study
title_fullStr Vitamin D inhibits pro-inflammatory cytokines in the airways of cystic fibrosis patients infected by Pseudomonas aeruginosa- pilot study
title_full_unstemmed Vitamin D inhibits pro-inflammatory cytokines in the airways of cystic fibrosis patients infected by Pseudomonas aeruginosa- pilot study
title_short Vitamin D inhibits pro-inflammatory cytokines in the airways of cystic fibrosis patients infected by Pseudomonas aeruginosa- pilot study
title_sort vitamin d inhibits pro-inflammatory cytokines in the airways of cystic fibrosis patients infected by pseudomonas aeruginosa- pilot study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440129/
https://www.ncbi.nlm.nih.gov/pubmed/30922377
http://dx.doi.org/10.1186/s13052-019-0634-x
work_keys_str_mv AT olszowiecchlebnam vitamindinhibitsproinflammatorycytokinesintheairwaysofcysticfibrosispatientsinfectedbypseudomonasaeruginosapilotstudy
AT koniarekmanieckaa vitamindinhibitsproinflammatorycytokinesintheairwaysofcysticfibrosispatientsinfectedbypseudomonasaeruginosapilotstudy
AT brzozowskaa vitamindinhibitsproinflammatorycytokinesintheairwaysofcysticfibrosispatientsinfectedbypseudomonasaeruginosapilotstudy
AT błauza vitamindinhibitsproinflammatorycytokinesintheairwaysofcysticfibrosispatientsinfectedbypseudomonasaeruginosapilotstudy
AT rychlikb vitamindinhibitsproinflammatorycytokinesintheairwaysofcysticfibrosispatientsinfectedbypseudomonasaeruginosapilotstudy
AT stelmachi vitamindinhibitsproinflammatorycytokinesintheairwaysofcysticfibrosispatientsinfectedbypseudomonasaeruginosapilotstudy